Home › Epilepsy › California › Los Angeles
Epilepsy clinical trials in Los Angeles, CA
6 studies for Epilepsy are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
RecruitingPhase 2
- University of California at Los Angeles, Los Angeles
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- Brain Science Research Institute, Los Angeles
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Recruiting
- University of California, Los Angeles, Los Angeles
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Southern California Keck Hospital, Los Angeles
- University of California Los Angeles, Los Angeles
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- University of California Los Angeles (UCLA), Los Angeles
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
- University of Southern California, Los Angeles
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA19 studies
- Houston, TX16 studies
- New York City, NY13 studies
- Washington, DC12 studies
- Philadelphia, PA11 studies
- Cleveland, OH9 studies
- Phoenix, AZ9 studies
- Durham, NC8 studies
- Rochester, MN8 studies
- Birmingham, AL7 studies
- Mountain View, CA7 studies
- St. Louis, MO7 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.